# Ropeginterferon for Treatment Free Remission

> **NCT07105319** · PHASE4 · COMPLETED · sponsor: **Dong-Wook Kim** · enrollment: 65 (actual)

## Conditions studied

- CML (Chronic Myelogenous Leukemia)

## Interventions

- **DRUG:** Ropeginterferon

## Key facts

- **NCT ID:** NCT07105319
- **Lead sponsor:** Dong-Wook Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07105319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07105319, "Ropeginterferon for Treatment Free Remission". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07105319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*